HEALTHYWAY INC (02587) announced its annual results for the period ending December 31, 2025. During the reporting period, the company demonstrated a steady improvement in its operating posture, with key operational metrics showing strong performance and achieving breakthroughs in both revenue and profitability. All business indicators saw significant enhancements.

For the fiscal year, HEALTHYWAY INC generated revenue of RMB 1.563 billion, representing a year-on-year increase of 30.13%. The company reported a net profit of RMB 54.338 million, marking a significant turnaround from a loss in the previous year and indicating a notable improvement in profitability. Gross profit rose to RMB 476 million, with the gross profit margin holding steady at 30.5%. The growth in total gross profit was primarily driven by the continued expansion of the company's overall business scale.

The substantial revenue growth during the period was mainly attributable to the company's proactive adjustments to its service structure and categories, with a focused effort on corporate services. Both the corporate services and digital marketing services segments exhibited robust growth, contributing revenue of RMB 1.356 billion, which accounted for a significant 86.8% of total revenue. It is noteworthy that within corporate services, sales of AI digital employees under the information technology services segment generated revenue exceeding RMB 32 million in 2025.

Regarding operational data, HEALTHYWAY INC continued to enhance its platform ecosystem, with steady growth in both users and partner resources. As of December 31, 2025, the number of registered individual users on the HEALTHYWAY platform increased to 223.1 million, up from 205.5 million at the end of 2024. The number of registered doctors grew from 889,000 to 934,000, and the number of hospitals connected to the platform rose from 11,762 to 12,870. These figures reflect the platform's expanding influence and deeper industry penetration.

In terms of return on equity, following the company's return to profitability, the group's return on equity improved significantly to 19.2% in 2025, representing a qualitative leap compared to the previous year.